NCT00592111View on ClinicalTrials.gov

A Comprehensive Study of Clinically Staged Pediatric Hodgkin's Disease: Chemotherapy for All Patients; Supplementary Low Dose Involved Field Irradiation for Selected Patients (CCG 5942)

PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

March 31, 1996

Primary Completion Date

February 28, 1999

Study Completion Date

January 31, 2008

Conditions
PediatricHodgkin's Disease
Interventions
DRUG

COPP/ABV

4 courses of COPP/ABV hybrid

DRUG

COPP/ABV

6 courses of COPP/ABV hybrid

DRUG

intensive chemo with concurrent growth factor

6 cycles (2 courses) of intensive chemotherapy with concurrent growth factor

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors
collaborator

Children's Cancer Group

OTHER

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00592111 - A Comprehensive Study of Clinically Staged Pediatric Hodgkin's Disease: Chemotherapy for All Patients; Supplementary Low Dose Involved Field Irradiation for Selected Patients (CCG 5942) | Biotech Hunter | Biotech Hunter